HOLMDEL, N.J., March 25, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its 2025 year-end investor call on Tuesday, March 31st at 10 a.m. ET with results issued prior the market opening. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Call Details Date / Time:Tuesday, March 31st at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. ...

Core Insights - BIO-key International, Inc. has received a new order worth $280,000 from a foreign defense ministry to expand its biometric user authentication deployment, bringing total business from this customer to $1.14 million over the past year [1] - The company has secured over $2 million in total orders from the military and defense sector in the last 12 months, indicating significant growth compared to the previous year [1] Group 1: Company Developments - The demand for BIO-key's biometric authentication solutions has increased due to rising geopolitical tensions, particularly in the Middle East, leading to a heightened need for secure authentication among defense and intelligence agencies [2] - BIO-key's platform supports phoneless and tokenless authentication for Sensitive Compartmented Information Facilities (SCIFs) and Foreign Material Exclusion (FME) areas, which are critical in defense operations [3] - The company now supports authentication for over 50,000 licensed users at the mentioned customer, showcasing its capability to scale to millions of users across large enterprises and government agencies [3] Group 2: Strategic Initiatives - BIO-key has been a trusted supplier to the defense ministry since 2017, emphasizing its commitment to delivering high security, usability, and ease of deployment [4] - The launch of BIO-key's Defense & Intelligence Cybersecurity Initiative in mid-2025 aims to provide hardened biometric authentication solutions to military and intelligence customers, which has already strengthened security for several new defense agency clients [4] - The company serves military, defense, and government agencies in multiple countries, including Europe and the Middle East, and anticipates continued growth in its Defense & Intelligence Cybersecurity Initiative due to rising global hostilities and cyber threats [4]

Group 1 - BIO-key International, Inc. will participate in the DealFlow Discovery Conference on January 28th and 29th, 2025, at the Borgata hotel in Atlantic City, New Jersey, inviting institutional investors, family offices, and high-net-worth investors to attend at no cost [1] - CEO Mike DePasquale will present at the conference and will be available for one-on-one meetings throughout the event, with presentation details to be posted on DealFlow's website in January [2] - The DealFlow Discovery Conference, formerly known as The Microcap Conference, has expanded to include both publicly traded microcaps and qualified private companies across various high-growth sectors [4] Group 2 - The conference is organized by DealFlow Events and aims to bring together hundreds of companies, investors, and dealmakers for presentations, expert discussions, and networking opportunities, providing a platform for companies to showcase their value propositions [5] - Keynote presentations and panel discussions will feature renowned industry figures discussing business, investing, and trends in US equity markets, tailored to the public microcap and private market communities [6] Group 3 - BIO-key is a provider of biometric-centric, multi-factor identity and access management (IAM) software, securing access for over 40 million users, and offers various authentication options including phoneless, tokenless, and passwordless solutions [7]

Core Insights - BIO-key International, Inc. is participating in the 2025 Gartner Identity & Access Management Summit to showcase its innovative passwordless authentication solutions aimed at enhancing security and reducing user friction [1][2][3] Company Overview - BIO-key specializes in identity and access management (IAM) solutions that are phoneless, tokenless, and passwordless, securing access for over 40 million users [6] - The company emphasizes the importance of identity-bound biometrics and alternative multi-factor authentication (MFA) methods to address IAM challenges [2][8] Event Participation - At the Gartner IAM Summit, BIO-key will demonstrate its advanced authentication technologies and engage with IAM leaders across various sectors, including finance, healthcare, and government [4][5] - The event will also feature discussions on emerging trends in IAM, such as deepfake detection and machine IAM [5] Authentication Solutions - BIO-key's solutions focus on eliminating reliance on passwords and physical tokens, thereby reducing attack surfaces and enhancing user experience [8] - The company aims to modernize IAM by providing cost-effective solutions that lower operational overhead related to password management [8]

Core Insights - BIO-key International, Inc. will host its third quarter investor call on November 14th at 10 a.m. ET, with results released before market opening [1] - The call will be led by Mike DePasquale, Chairman & CEO, and Cecilia Welch, CFO, and will include a Q&A session [1] Company Overview - BIO-key is a leader in Identity and Access Management (IAM) and biometric authentication technologies, securing access for over 40 million users [3] - The company offers a multi-factor identity and access management software that includes phoneless, tokenless, and passwordless biometric options [3] - Its PortalGuard IAM solution is available in both cloud-hosted and on-premise formats, providing cost-effective and secure access to various applications and transactions [3]

Core Insights - BIO-key International, Inc. has entered into a warrant inducement agreement with an institutional investor to exercise outstanding warrants, resulting in the purchase of 3,091,668 shares at a reduced price of $1.02 per share, generating approximately $3.1 million in gross proceeds [1][3] Group 1: Warrant Inducement Agreement - The investor will exercise Series A and Series B Warrants to purchase 3,091,668 shares at $1.02 per share [1] - In exchange, the company will issue unregistered New Warrants for 6,183,336 shares at the same exercise price of $1.02, which are immediately exercisable and expire in five years [3] - The company plans to file a registration statement with the SEC for the resale of shares from the New Warrants [3] Group 2: Company Overview - BIO-key is focused on biometric authentication and Identity and Access Management (IAM) solutions, securing access for over 40 million users [4] - The company offers various authentication methods, including phoneless, tokenless, and passwordless options, through its PortalGuard IAM solution [4]

Company Overview - BIO-key International, Inc. is an innovative provider of workforce and customer Identity and Access Management solutions featuring passwordless, phoneless, and tokenless Identity-Bound Biometric authentication [1] - The company secures access for over forty million users through its biometric-centric, multi-factor identity and access management (IAM) software [2] Upcoming Events - BIO-key will host its second quarter 2025 investor call on August 13th at 10 a.m. ET, with results released before the stock market opens [1] - The call will be led by Mike DePasquale, Chairman & CEO, and Cecilia Welch, CFO, and will include a Q&A session [1] Call Details - The investor call can be accessed via dial-in numbers: 1-877-418-5460 for U.S. and 1-412-717-9594 for international participants [2] - A live webcast and replay will be available for three months [2] - Audio replay can be accessed at 1-877-344-7529 for U.S. and 1-412-317-0088 for international, using code 8281392 [2] Engagement Channels - BIO-key maintains a presence on various social media platforms including Facebook, LinkedIn, and X [3] - Investor contacts are available through Catalyst IR for further inquiries [3]

Core Insights - BIO-key International, Inc. has joined ISMS Forum, Spain's leading cybersecurity association, to enhance its commitment to cybersecurity resilience and robust security strategies in Spain [1][2] - The collaboration aims to drive innovation in identity and access management, Zero Trust security, and regulatory compliance [2] Company Overview - BIO-key is a leader in Identity and Access Management (IAM) and biometric authentication solutions, securing access for over 40 million users [4] - The company offers a range of authentication options, including phoneless, tokenless, and passwordless biometric solutions, through its PortalGuard IAM software [4] Industry Context - ISMS Forum promotes best practices, innovation, and knowledge-sharing to strengthen cybersecurity resilience across various industries in Spain [3] - The organization plays a key role in shaping the cybersecurity landscape through working groups, research initiatives, and conferences [3]

Core Insights - BIO-key International, Inc. has received over $600K in new orders from a prominent defense ministry for its biometric user authentication solutions, which include both hardware and software to be delivered in the current quarter [1][2]. Group 1: Company Overview - BIO-key specializes in identity and access management (IAM) solutions that utilize Identity-Bound Biometrics (IBB) for secure authentication without the need for tokens or passwords [1][5]. - The company’s biometric authentication platform is noted for being more reliable, cost-effective, and secure compared to traditional hardware security keys [3]. Group 2: Recent Developments - The defense ministry has integrated BIO-key's biometric solution into programs that provide authentication access to digital services for over 47,000 users, utilizing more than 40,000 fingerprint scanners [2]. - BIO-key anticipates further awards as the defense ministry expands its use of the biometric solutions [2]. Group 3: Strategic Importance - The deployment of BIO-key's technology is seen as a significant endorsement of its innovation and capability, as the defense ministry is recognized as a leader in cybersecurity technologies [4]. - The company aims to grow its presence in high-stakes applications within the defense sector, building on its existing customer base across various industries including government, manufacturing, finance, and retail [4].

Company Participation - BIO-key International, Inc. will participate in the Aegis Capital Corp. 2025 Virtual Conference on May 22, 2025, and the Maxim Virtual Tech Conference on June 4, 2025 [1][2] Conference Details - The Aegis Capital Virtual Conference presentation is scheduled for May 22, 2025, from 11:30 to 11:55 a.m. ET [2] - The Maxim Virtual Tech Conference will feature a fireside chat with Maxim Analyst Jack Vander Aarde on June 4, 2025, at 11:00 a.m. ET [2] Company Overview - BIO-key is a provider of Identity and Access Management (IAM) solutions, focusing on passwordless, phoneless, and tokenless biometric authentication, securing access for over 40 million users [4] - The company's PortalGuard IAM solution offers a cost-effective and secure way to access computers, information, applications, and high-value transactions [4]